UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
SNUH to introduce Toshiba’s heavy ion radiotherapy device
Seoul National University Hospital (SNUH) signed a contract on Monday to in...
by Shim Hyun-tai
|
2020-08-31 14:02
라인
2 developers of Covid-19 test kits prepare IPO in September
Two domestic developers of Covid-19 diagnostic kits are preparing to go pub...
by Kim Chan-hyuk
|
2020-08-31 13:53
라인
Collaboration: One way to simplify complexities in drug development
The rapidly expanding global healthcare industry has created intensifying d...
by Lee Han-soo
|
2020-08-31 13:52
라인
As cumulative caseload nears 20,000, ‘no-move’ week in capital area
Korea's new virus cases stayed below 300 on Sunday, but massive outbrea...
by Lee Han-soo
|
2020-08-31 12:58
라인
‘AI MRI model can diagnose autism’s severity, prognosis’
A Severance-KAIST research team has affirmed that deep learning using brain...
by Shim Hyun-tai
|
2020-08-28 18:04
라인
Regulator names 2 more innovative medical devices
The Ministry of Food and Drug Safety has designated clinical decision suppo...
by Shim Hyun-tai
|
2020-08-28 18:03
라인
Doctors’ group head calls President Moon ‘fascist’
After President Moon Jae-in threatened to take strong measures against doct...
by Choi Gwang-seok
|
2020-08-28 16:00
라인
Takeda’s Alunbrig available as primary therapy for lung cancer
The Ministry of Food and Drug Safety has approved Takeda Korea’s Alunbrig (...
by Shim Hyun-tai
|
2020-08-28 15:52
라인
Drugmakers boost production capacity amid Covid-19
Local pharmaceutical companies are expanding their manufacturing facilities...
by Kim Chan-hyuk
|
2020-08-28 14:57
라인
Capital area tops Daegu as Covid-19 epicenter
Korea’s new virus cases sank below 400 on Thursday but cluster infections c...
by Shim Hyun-tai
|
2020-08-28 14:54
라인
Government threatens to imprison doctors who defy return-to-work order
The Ministry of Health and Welfare said it has extended the order nationwid...
by Kwak Sung-sun
|
2020-08-28 14:54
라인
‘Thyroid surgery using oral endoscopy reduces swallowing difficulties’
A research team of Seoul National University (SNU) Boramae Medical Center r...
by Shim Hyun-tai
|
2020-08-27 18:06
라인
SNUH opens new Covid-19 treatment center in 2 days
Seoul National University Hospital (SNUH) said Thursday that it opened a la...
by Shim Hyun-tai
|
2020-08-27 18:06
라인
Genexine's cytokine drug effective on severe Covid-19 patients
Genexine said Thursday that it has confirmed the safety and efficacy of lon...
by Shim Hyun-tai
|
2020-08-27 18:05
라인
Korea publishes guidelines for digital therapeutics
The Ministry of Food and Drug Safety has published the guidelines for winni...
by Kim Yun-mi
|
2020-08-27 18:05
라인
Drugmakers to sue government for limiting choline alfoscerate benefit
Manufacturers of choline alfoscerate, a dementia drug, are reportedly prepa...
by Kim Yun-mi
|
2020-08-27 14:26
라인
Stocks of 3 Covid-19 vaccine developers spike
Three Korean drugmakers working on a Covid-19 vaccine have garnered robust ...
by Kim Chan-hyuk
|
2020-08-27 14:07
라인
New virus cases reach six-month high; tightest restrictions imminent
Korea reported new Covid-19 cases of more than 400 for the first time in si...
by Shim Hyun-tai
|
2020-08-27 13:24
라인
Helixmith’s antibody therapy shows efficacy in immunoglobulin kidney disease
A joint research team of Helixmith and Seoul National University College of...
by Shim Hyun-tai
|
2020-08-26 17:47
라인
Celltrion to begin P1 trial of antibody-drug on mild Covid-19 patients
Celltrion has begun recruiting mild Covid-19 patients for the Phase 1 clini...
by Shim Hyun-tai
|
2020-08-26 17:17
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top